MedicarePartD.guide

A non-government resource built from CMS public data

IPOL 40/8/32 [D'ag'U]/.5mL Injection, Suspension

Also known as Poliovirus Type 1 Antigen (Formaldehyde Inactivated), Poliovirus Type 2 Antigen (Formaldehyde Inactivated), And Poliovirus Type 3 Antigen (Formaldehyde Inactivated). Coverage in Puerto Rico (CMS PDP Region 38).

3 of 3 stand-alone Part D plans in Puerto Rico cover this drug on tier 3.

1 of 3 plans apply a prior authorization, step therapy or quantity limit.

62 Medicare Advantage plans in PR do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. PR: 62 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
HealthSpring Extra Rx (PDP)$50.00/mo premium · $615.00 deductible3Preferred Brand17%17%$44.7747—None
HealthSpring Assurance Rx (PDP)$65.70/mo premium · $615.00 deductible3Preferred Brand22%22%$44.7280—None
AARP Medicare Rx Preferred from UHC (PDP)$145.10/mo premium · $615.00 deductible3Preferred Brand25%25%$96.7948$1,451.9215 units
  • Quantity limit 0.5 per 1 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →